These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 15150205

  • 1. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.
    Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME, Martin PJ.
    JAMA; 2004 May 19; 291(19):2335-43. PubMed ID: 15150205
    [Abstract] [Full Text] [Related]

  • 2. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz MA, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W.
    Cancer; 2017 May 15; 123(10):1828-1838. PubMed ID: 28102896
    [Abstract] [Full Text] [Related]

  • 3. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning.
    Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM.
    Bone Marrow Transplant; 1993 Apr 15; 11(4):319-27. PubMed ID: 8485479
    [Abstract] [Full Text] [Related]

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 5. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen YA, Lee SS, Temel JS.
    JAMA; 2016 Nov 22; 316(20):2094-2103. PubMed ID: 27893130
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R, Van Heijzen K, Palmer A, Komiya A, Slovak ML, Chang KL, Fung H, Krishnan A, Molina A, Nademanee A, O'Donnell M, Popplewell L, Rodriguez R, Forman SJ, Bhatia S.
    J Clin Oncol; 2005 Sep 20; 23(27):6699-711. PubMed ID: 16170178
    [Abstract] [Full Text] [Related]

  • 7. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ.
    Biol Blood Marrow Transplant; 2009 Sep 20; 15(9):1100-7. PubMed ID: 19660723
    [Abstract] [Full Text] [Related]

  • 8. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation.
    El-Jawahri AR, Vandusen HB, Traeger LN, Fishbein JN, Keenan T, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Spitzer TR, Chen YB, Temel JS.
    Cancer; 2016 Mar 01; 122(5):806-12. PubMed ID: 26650840
    [Abstract] [Full Text] [Related]

  • 9. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
    Maruyama D, Fukuda T, Kato R, Yamasaki S, Usui E, Morita-Hoshi Y, Kim SW, Mori S, Heike Y, Makimoto A, Tajima K, Tanosaki R, Tobinai K, Takaue Y.
    Biol Blood Marrow Transplant; 2007 Aug 01; 13(8):932-41. PubMed ID: 17640597
    [Abstract] [Full Text] [Related]

  • 10. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL, Dueck AC, Fauble VD, Sproat LO, Reeder CB, Noel P, Khera N, Betcher JA, Klein JL, Leis JF, Adams RH.
    Biol Blood Marrow Transplant; 2013 Aug 01; 19(8):1167-74. PubMed ID: 23664940
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS, Edelman JD, Madtes DK, Martin PJ, Flowers ME.
    Biol Blood Marrow Transplant; 2014 Aug 01; 20(8):1169-75. PubMed ID: 24727334
    [Abstract] [Full Text] [Related]

  • 12. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I, Simpson JM, Dodds AJ, Ma DD, Szer J, Bradstock KF.
    Biol Blood Marrow Transplant; 2009 Oct 01; 15(10):1323-30. PubMed ID: 19747641
    [Abstract] [Full Text] [Related]

  • 13. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K.
    Nephrol Dial Transplant; 2010 Jan 01; 25(1):278-82. PubMed ID: 19762604
    [Abstract] [Full Text] [Related]

  • 14. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation.
    Hjermstad MJ, Loge JH, Evensen SA, Kvaløy SO, Fayers PM, Kaasa S.
    Bone Marrow Transplant; 1999 Dec 01; 24(11):1219-28. PubMed ID: 10642812
    [Abstract] [Full Text] [Related]

  • 15. The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.
    McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M.
    Brain Behav Immun; 2013 Mar 01; 30 Suppl(Suppl):S142-8. PubMed ID: 22910186
    [Abstract] [Full Text] [Related]

  • 16. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.
    Wong FL, Francisco L, Togawa K, Bosworth A, Gonzales M, Hanby C, Sabado M, Grant M, Forman SJ, Bhatia S.
    Blood; 2010 Mar 25; 115(12):2508-19. PubMed ID: 20089962
    [Abstract] [Full Text] [Related]

  • 17. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS.
    Biol Blood Marrow Transplant; 2008 Jun 25; 14(6):658-63. PubMed ID: 18489991
    [Abstract] [Full Text] [Related]

  • 18. Psychological distress in long-term survivors of hematopoietic stem cell transplantation.
    Rusiewicz A, DuHamel KN, Burkhalter J, Ostroff J, Winkel G, Scigliano E, Papadopoulos E, Moskowitz C, Redd W.
    Psychooncology; 2008 Apr 25; 17(4):329-37. PubMed ID: 17621377
    [Abstract] [Full Text] [Related]

  • 19. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.
    Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.
    Biol Blood Marrow Transplant; 2015 Nov 15; 21(11):2008-16. PubMed ID: 26211985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.